Related Experiment Video
Updated: Feb 3, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Identification of Mutated Cancer Driver Genes in Unpaired RNA-Seq Samples
1Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA. davidm@jimmy.harvard.edu.
Abstract:
The identification of cancer driver genes through the analysis of mutations detected with high-throughput sequencing is a useful tool and a key challenge in cancer genomics. The workflow presented here relies on unpaired RNA-seq tumoral samples, thus leveraging already available RNA-seq data and providing the intrinsical benefits of directly targeting the transcriptome. Based on well-established methods for variant detection, this workflow also involves thorough data cleaning and extensive annotation, which enable the selection for somatic mutations with functional impact and the prioritization of genes relevant to the carcinogenic processes in the input samples.
Insights
Identifying cancer driver genes is crucial. This workflow uses RNA-sequencing data to find functional mutations and prioritize genes involved in cancer development.
Area of Science:
- Genomics
- Cancer Biology
- Bioinformatics
Background:
- High-throughput sequencing generates vast amounts of data for cancer genomics.
- Identifying cancer driver genes is essential for understanding oncogenesis.
- Leveraging existing RNA-sequencing (RNA-seq) data offers an efficient approach.
Purpose of the Study:
- To present a robust workflow for identifying cancer driver genes.
- To utilize unpaired tumor RNA-seq samples for transcriptome analysis.
- To enable the prioritization of genes implicated in carcinogenic processes.
Main Methods:
- The workflow employs established variant detection methods.
- It incorporates rigorous data cleaning and comprehensive annotation steps.
- Analysis focuses on somatic mutations with potential functional impact.
Main Results:
- The workflow effectively leverages unpaired tumor RNA-seq data.
- It facilitates the selection of functionally significant somatic mutations.
- Prioritization of cancer-relevant genes is achieved through detailed annotation.
Conclusions:
- This RNA-seq based workflow provides a valuable tool for cancer driver gene identification.
- The approach enhances the utility of existing RNA-seq data for cancer genomics research.
- It aids in pinpointing genes critical to tumor development and progression.
Related Concept Videos
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Mutation, Gene Flow, and Genetic Drift
Mutations
Viral Mutations
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

